Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

Full description

Bibliographic Details
Main Authors: Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Molecular Oncology
Subjects:
chromosomal instability
genomic profiling
newly diagnosed glioblastoma
NTRK fusion
translational relevance
tumor mutational burden
Online Access:https://doi.org/10.1002/1878-0261.12790

Internet

https://doi.org/10.1002/1878-0261.12790

Similar Items